Sign in

CIK 0001088856

  • Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770487658
Phone
+1 650-688-8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
  1. 4 Derivatives Options or other derivatives
  2. 4 Planned sale Director sold 2,200 shares at $70.61 ($155,342)
  3. 4 Planned sale Chief Development Officer sold 20,000 shares at an average $72.42 ($1,448,475)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Planned sale Chief Executive Officer sold 40,000 shares at an average $82.86 ($3,314,310)
  8. 4 Planned sale See Remarks sold 5,000 shares at an average $78.04 ($390,218)
  9. 4 Planned sale See Remarks sold 20,000 shares at an average $79.08 ($1,581,686)
  10. 4 Grant or award Chief Business Officer acquired 1,994 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 1,550 shares (grant or award)
  12. 4 Option exercise See Remarks acquired 10,000 shares (option exercise)
  13. 4 Open-market sale Chief Business Officer sold 2,279 shares at $75.85 ($172,862)
  14. 4 Planned sale Chief Development Officer sold 32,262 shares at $74.17 ($2,393,014)
  15. 4 Open-market sale Director sold 27,352 shares at an average $74.23 ($2,030,452)
  16. 4 Planned sale Director sold 2,200 shares at an average $72.06 ($158,526)
  17. 4 Planned sale Chief Development Officer sold 7,060 shares at $74.31 ($524,653)
  18. 4 Planned sale See Remarks sold 39,410 shares at an average $72.13 ($2,842,769)
  19. 4 Planned sale Chief Executive Officer sold 40,000 shares at an average $72.90 ($2,915,922)
  20. 4 Planned sale See Remarks sold 9,350 shares at $71.96 ($672,781)

Page 8 of 60 · 1,196 filings